Clinical Significance of CD147 in Children with Inflammatory Bowel Disease
- PMID: 33015178
- PMCID: PMC7516708
- DOI: 10.1155/2020/7647181
Clinical Significance of CD147 in Children with Inflammatory Bowel Disease
Abstract
Background: CD147/basigin (Bsg), a transmembrane glycoprotein, activates matrix metalloproteinases and promotes inflammation.
Objective: The aim of this study is to explore the clinical significance of CD147 in the pathogenesis of inflammatory bowel disease (IBD).
Results: In addition to monocytes, the clinical analysis showed that there is no significance obtained in leucocyte, neutrophil, eosinophil, basophil, and erythrocyte between IBD and controls. Immunohistochemistry analysis showed that CD147 was increased in intestinal tissue of patients with active IBD compared to that in the control group. What is more, CD147 is involved in intestinal barrier function and intestinal inflammation, which was attributed to the fact that it has an influence on MCT4 expression, a regulator of intestinal barrier function and intestinal inflammation, in HT-29 and CaCO2 cells. Most importantly, serum level of CD147 content is higher in active IBD than that in inactive IBD or healthy control, which could be a biomarker of IBD.
Conclusion: The data suggested that increased CD147 level could be a biomarker of IBD in children.
Copyright © 2020 Hongli Wang et al.
Conflict of interest statement
The authors declared that they have no competing interests.
Figures



Similar articles
-
CD147 Aggravated Inflammatory Bowel Disease by Triggering NF-κB-Mediated Pyroptosis.Biomed Res Int. 2020 Jun 30;2020:5341247. doi: 10.1155/2020/5341247. eCollection 2020. Biomed Res Int. 2020. PMID: 32714980 Free PMC article.
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
-
Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel Disease.Biomed Res Int. 2018 Dec 10;2018:5140691. doi: 10.1155/2018/5140691. eCollection 2018. Biomed Res Int. 2018. PMID: 30643810 Free PMC article. Clinical Trial.
-
Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis.Front Immunol. 2021 Jul 29;12:655960. doi: 10.3389/fimmu.2021.655960. eCollection 2021. Front Immunol. 2021. PMID: 34394073 Free PMC article.
-
Role of CD147 (EMMPRIN/Basigin) in Tissue Remodeling.Anat Rec (Hoboken). 2020 Jun;303(6):1584-1589. doi: 10.1002/ar.24089. Epub 2019 Mar 15. Anat Rec (Hoboken). 2020. PMID: 30768865 Review.
Cited by
-
COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations.Medicina (Kaunas). 2023 Sep 24;59(10):1709. doi: 10.3390/medicina59101709. Medicina (Kaunas). 2023. PMID: 37893427 Free PMC article. Review.
-
CD147 Targeting by AC-73 Induces Autophagy and Reduces Intestinal Fibrosis Associated with TNBS Chronic Colitis.J Crohns Colitis. 2022 Nov 23;16(11):1751-1761. doi: 10.1093/ecco-jcc/jjac084. J Crohns Colitis. 2022. PMID: 35833587 Free PMC article.
-
Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison?World J Gastroenterol. 2021 May 21;27(19):2270-2280. doi: 10.3748/wjg.v27.i19.2270. World J Gastroenterol. 2021. PMID: 34040321 Free PMC article. Review.
-
Autophagy in intestinal fibrosis: relevance in inflammatory bowel disease.Front Pharmacol. 2023 Jun 15;14:1170436. doi: 10.3389/fphar.2023.1170436. eCollection 2023. Front Pharmacol. 2023. PMID: 37397491 Free PMC article. Review.
References
-
- Holmberg F. E. O., Pedersen J., Jørgensen P., Soendergaard C., Jensen K. B., Nielsen O. H. Intestinal barrier integrity and inflammatory bowel disease: stem cell-based approaches to regenerate the barrier. Journal of Tissue Engineering and Regenerative Medicine. 2018;12(4):923–935. doi: 10.1002/term.2506. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous